Author:
Siavash Sazideh ,Masoud Reza Shishehbore
Reference46 articles.
1. Ghanghoria, R., Kesharwani, P., Tekade, R.K., and Jain, N.K., Targeting luteinizing hormone-releasing hormone: a potential therapeutics to treat gynecological and other cancers, J. Control. Release, 2018, vol. 26, p. 277.
2. Blandino, G. and Di Agostino, S., New therapeutic strategies to treat human cancers expressing mutant p53 proteins, J. Exp. Clin. Cancer Res., 2018, vol. 37, p. 30.
3. Albright, B.B., Delgado, M.K., Latif, N.A., Giuntoli, R.L., Ko, E.M., and Haggerty, A.F., Treat and release emergency department utilization by patients with gynecologic cancers: national estimates and trends, Gynecol. Oncol., 2018, vol. 149, p. 141.
4. Moradi-Marjaneh, R.S., Hassanian, M., Hasanzadeh, M., Rezayi, M., Maftouh, M., Mehramiz, M., and Avan, A., Therapeutic potential of toll like receptors in treatment of gynecological cancers, IUBMB Life, 2019, vol. 71, p. 549.
5. Fymat, A.L., Harnessing the immune system to treat cancers and neurodegenerative diseases, J. Clin. Res. Neurol., 2018, vol. 1, p. 1.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献